SCHEMBL4868971

SCHEMBL4868971

Cc1cc(S(=O)(=O)NCC(=O)Nc2ccc(Cl)cc2Cc2ccccc2Cl)c(C)cc1Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.41
LMNA P02545 4/20 0.41
ALDH1A1 P00352 3/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
NPSR1 Q6W5P4 1/20 0.41
PTGES O14684 1/20 0.41
IDH1 O75874 3/20 0.40
ALOX12 P18054 1/20 0.39
GFER P55789 1/20 0.39
EPHX2 P34913 1/20 0.38
HSD17B1 P14061 1/20 0.38
HSD17B2 P37059 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
MEP1B Q16820 1/20 0.38
POLB P06746 1/20 0.38
THRB P10828 1/20 0.38
KCNJ6 P48051 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3250641 0.95 MAPT (0.42) MAPTLMNAALDH1A1MEN1KMT2A
SCHEMBL3249346 0.94 MAPT (0.41) MAPTLMNAALDH1A1MEN1KMT2A
SCHEMBL3244433 0.90 PTGES (0.44) MAPTLMNAALDH1A1MEN1KMT2A
SCHEMBL3256141 0.88 PTGES (0.47) MAPTLMNAALDH1A1MEN1KMT2A
SCHEMBL3251395 0.86 MAPT (0.49) MAPTLMNAALDH1A1MEN1KMT2A
SCHEMBL4860809 0.84 L3MBTL1 (0.46) MAPTLMNAALDH1A1MEN1KMT2A
SCHEMBL3266444 0.84 ALDH1A1 (0.44) MAPTLMNAALDH1A1MEN1KMT2A
SCHEMBL3251190 0.84 ALDH1A1 (0.46) MAPTLMNAALDH1A1MEN1KMT2A
SCHEMBL3251138 0.83 GAA (0.47) MAPTLMNAALDH1A1MEN1KMT2A
SCHEMBL3249160 0.83 ALDH1A1 (0.53) MAPTLMNAALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7396958-B2 Sulphonamide derivatives, their preparation and their therapeutic application SANOFI AVENTIS (FR) 2008-07-08 US disclosed
US-20070185136-A1 SULPHONAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION SANOFI-AVENTIS (FR) 2007-08-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070185136-A1 SULPHONAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION HCRTR2, GIPR, SSTR2 MAPT 3113/4885LMNA 3046/4885ALDH1A1 2179/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.